249 related articles for article (PubMed ID: 10796893)
1. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors.
Adams PC; Kertesz AE; McLaren CE; Barr R; Bamford A; Chakrabarti S
Hepatology; 2000 May; 31(5):1160-4. PubMed ID: 10796893
[TBL] [Abstract][Full Text] [Related]
2. HFE mutations, iron deficiency and overload in 10,500 blood donors.
Jackson HA; Carter K; Darke C; Guttridge MG; Ravine D; Hutton RD; Napier JA; Worwood M
Br J Haematol; 2001 Aug; 114(2):474-84. PubMed ID: 11529872
[TBL] [Abstract][Full Text] [Related]
3. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
[TBL] [Abstract][Full Text] [Related]
4. Unsaturated iron binding capacity and transferrin saturation are equally reliable in detection of HFE hemochromatosis.
Murtagh LJ; Whiley M; Wilson S; Tran H; Bassett ML
Am J Gastroenterol; 2002 Aug; 97(8):2093-9. PubMed ID: 12190182
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
[TBL] [Abstract][Full Text] [Related]
6. Biological variability of transferrin saturation and unsaturated iron-binding capacity.
Adams PC; Reboussin DM; Press RD; Barton JC; Acton RT; Moses GC; Leiendecker-Foster C; McLaren GD; Dawkins FW; Gordeuk VR; Lovato L; Eckfeldt JH
Am J Med; 2007 Nov; 120(11):999.e1-7. PubMed ID: 17976429
[TBL] [Abstract][Full Text] [Related]
7. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
[TBL] [Abstract][Full Text] [Related]
8. HFE based re-evaluation of heterozygous hemochromatosis.
Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
[TBL] [Abstract][Full Text] [Related]
9. Population screening for hemochromatosis: a study in 5370 Spanish blood donors.
Sánchez M; Villa M; Ingelmo M; Sanz C; Bruguera M; Ascaso C; Oliva R
J Hepatol; 2003 Jun; 38(6):745-50. PubMed ID: 12763366
[TBL] [Abstract][Full Text] [Related]
10. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.
Thorstensen K; Kvitland MA; Irgens WØ; Hveem K; Asberg A
Scand J Clin Lab Invest; 2010 Apr; 70(2):92-7. PubMed ID: 20073670
[TBL] [Abstract][Full Text] [Related]
11. Genotype screening for hereditary hemochromatosis among voluntary blood donors in Hungary.
Andrikovics H; Kalmár L; Bors A; Fandl B; Petri I; Kalász L; Tordai A
Blood Cells Mol Dis; 2001; 27(1):334-41. PubMed ID: 11358395
[TBL] [Abstract][Full Text] [Related]
12. Transferrin saturation phenotype and HFE genotype screening for hemochromatosis and primary iron overload: predictions from a model based on national, racial, and ethnic group composition in central Alabama.
Barton JC; Acton RT
Genet Test; 2000; 4(2):199-206. PubMed ID: 10953960
[TBL] [Abstract][Full Text] [Related]
13. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives.
Moirand R; Jouanolle AM; Brissot P; Le Gall JY; David V; Deugnier Y
Gastroenterology; 1999 Feb; 116(2):372-7. PubMed ID: 9922318
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.
Adams PC; Reboussin DM; Leiendecker-Foster C; Moses GC; McLaren GD; McLaren CE; Dawkins FW; Kasvosve I; Acton RT; Barton JC; Zaccaro D; Harris EL; Press R; Chang H; Eckfeldt JH
Clin Chem; 2005 Jun; 51(6):1048-52. PubMed ID: 15833784
[No Abstract] [Full Text] [Related]
16. Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population.
Rossi E; Bulsara MK; Olynyk JK; Cullen DJ; Summerville L; Powell LW
Clin Chem; 2001 Feb; 47(2):202-8. PubMed ID: 11159767
[TBL] [Abstract][Full Text] [Related]
17. Relation between HFE mutations and mild iron-overload expression.
Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
[TBL] [Abstract][Full Text] [Related]
18. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
Pedersen P; Milman N
Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
[TBL] [Abstract][Full Text] [Related]
19. Frequency of HFE mutations among Turkish blood donors according to transferrin saturation: genotype screening for hereditary hemochromatosis among voluntary blood donors in Turkey.
Simsek H; Sumer H; Yilmaz E; Balaban YH; Ozcebe O; Hascelik G; Buyukask Y; Tatar G
J Clin Gastroenterol; 2004 Sep; 38(8):671-5. PubMed ID: 15319650
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of hemochromatosis in family members of probands: a comparison of phenotyping and HFE genotyping.
Barton JC; Rothenberg BE; Bertoli LF; Acton RT
Genet Med; 1999; 1(3):89-93. PubMed ID: 11336458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
